Humana: Another Early Victim Of The Debt Deal

stethoscope american flag healthcare

Analysts had been bullish on healthcare stocks this year. But fears of Medicare cuts, and cuts to other federal health programs, from the debt deal, sparked a major sell-off yesterday.

Health insurer Humana Inc. fell 2.98% yesterday, despite posting a 35% rise in Q2 profits, crushing Wall Street’s estimates. The company’s profits were pushed by a jump in customers signing up for its Medicare plans and lower claims.

Here’s what analysts make of the stock:

  • Barclays analyst Joshua Raskin said on the back of strong results he was raising 2011 EPS estimate to $7.50 per share, from previous estimate of $6.80. In the absence of one-time items, there was no doubt on the strength of the results.
  • Deutsche Bank analysts believe Medicare concerns will weigh on the stock. The company’s growth and profits look to be strong but a difficult medicare reimbursement outlook is dragging the sector as a whole. 
  • David Windley at Jefferies is bullish on the stock. He says for the moment, the stock is going down, even if the underlying business is doing well.

Meanwhile, at a conference call, Humana Inc.’s CEO Michael B. McCallister said the company would spend on wellness initiatives, and sales and marketing for Medicare plans, (via MSNBC):

“I’m just signaling today that barring something unusual, we should have a good ’12 in Medicare, and that’s why we’re willing to spend the money we’re preparing to spend in the latter part of this year, to prepare for it.”

Don’t Miss: 47 Depressing Facts About The Healthcare System That Will Make You Beg For Reform >

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.